AstraZeneca PLC Third quarter and nine months results 2011

Thursday, 27 October 2011

David Brennan, Chief Executive Officer said:

"We have delivered a third quarter revenue and Core earnings performance in line with our expectations, against the backdrop of anticipated generic competition and government price interventions. Our disciplined execution continues to generate strong cash returns, with dividends and net share repurchases well ahead of last year. We have also increased our Core EPS target for the full year."

Third quarter and nine months results

Announced on Thursday 27 October 2011



  • Corporate and financial
  • Science